EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Mangoceuticals, Inc. (MGRX) had EBIT Margin of -1502.45% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.07M |
|
$-1.31M |
|
$0.02M |
|
$0.04M |
|
$1.10M |
|
$-1.03M |
|
$-0.28M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.31M |
|
$-1.03M |
|
$-0.74M |
|
17.12M |
|
17.12M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$0.25M |
|
$0.00M |
|
$13.93M |
|
$14.17M |
|
$1.40M |
|
-- |
|
$0.25M |
|
$1.65M |
|
$12.52M |
|
$-1.12M |
|
$12.52M |
|
18.02M |
|
| Cash Flow Statement Financials | |
$-1.57M |
|
$0.00M |
|
$0.32M |
|
$1.49M |
|
$0.23M |
|
$-1.26M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.18 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
64.31% |
|
-1502.45% |
|
|
EBIT Margin |
-1502.45% |
-- |
|
-1909.52% |
|
-1909.12% |
|
$-1.57M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-10.48% |
|
116.94% |
|
-9.26% |
|
-10.48% |
|
$0.70 |
|
$-0.09 |
|
$-0.09 |
|